«. Lacour and . Le, droit des brevets d'invention à l'épreuve des nanotechnologies », Techniques de l'ingénieur, 2010.

A. Hullmann, « Capturing Nanotechnology's Current State of Development via Analysis of Patents », STI Working Paper Statistical Analysis of Science, Technology and Industry, OECD 62 Cf. Raj Bawa, Patents and nanomedicine 63 The United States Patent and Trademark Office (USPTO) created a new filing class number 977 for nanotechnologies in November of 2004. The European Patent Office (EPO) has created an internal classification for prior art examinations of submitted patent applications named Y01N. 64 The concept of the « tragedy of the anti-commons ». This concept has been modelized concerning the subject of patents in the field of biomédical research in Can Patents Deter Innovation? The Anticommons, 21 and following, pp.351-374, 1998.

C. Shapiro, Navigating the Patent Thicket: Cross licences, Patent pools and Standard-Setting Politique des brevets : l'enjeu central de la qualité, face à l'évolution des pratiques, Horizons stratégiques, Conference on Innovation Policy and the Economy, pp.janvier-mars, 2001.

A. Kahn, Les brevets sont devenus des armes sophistiquées de guerre commerciale, Le Monde, Paris, 26 février 2008. translation : « Patents have become sophisticated arms of commercial war

M. Van-velzen, IP in nanomedicine ??? Perspective from an IP professional in industry, World Patent Information, vol.30, issue.4, pp.294-299, 2008.
DOI : 10.1016/j.wpi.2008.01.005